{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:58:17Z","timestamp":1780095497038,"version":"3.54.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.mjafi.2012.09.006","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T06:01:24Z","timestamp":1351922484000},"page":"294-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["JAK2 V617F negative essential thrombocythemia"],"prefix":"10.1016","volume":"69","author":[{"given":"A.W.","family":"Kashif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mjafi.2012.09.006_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1600-0609.2000.90236.x","article-title":"Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area","volume":"65","author":"Jensen","year":"2000","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.mjafi.2012.09.006_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00296-005-0595-9","article-title":"Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis","volume":"26","author":"Hur","year":"2005","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.mjafi.2012.09.006_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0190-9622(91)70010-Y","article-title":"Cutaneous manifestations in patients with essential thrombocythemia","volume":"24","author":"Itin","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mjafi.2012.09.006_bib4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.5858\/2006-130-1144-ET","article-title":"Essential thrombocythemia: a review of diagnostic and pathologic features","volume":"130","author":"Sanchez","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.mjafi.2012.09.006_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.mjafi.2012.09.006_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","article-title":"BCSH guidelines for investigation and management of patients presenting with a thrombocytosis","volume":"149","author":"Harrison","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mjafi.2012.09.006_bib7","series-title":"WHO Classification of Tum-ours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.mjafi.2012.09.006_bib8","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2006-09-046342","article-title":"Leukocytosis is a risk factor for thrombosis in essential thrombocythemia : interaction with treatment, standard risk factors and JAK2 mutation status","volume":"109","author":"Carobbio","year":"2007","journal-title":"Blood"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123712002304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123712002304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:41:54Z","timestamp":1759837314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123712002304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0377123712002304"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2012.09.006","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK2 V617F negative essential thrombocythemia","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2012.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}